Literature DB >> 15020025

The trials and tribulations of intrapartum studies.

Vanora Hundley1, Helen Cheyne.   

Abstract

OBJECTIVE: To review the reporting of randomised controlled trials for intrapartum interventions.
METHODS: This was a literature search addressing the period from the publication of the CONSORT statement i.e. 1996-2002. Databases searched: Medline and CINAHL. Search terms: pregnancy, low-risk, normal, intrapartum, labour and labor. INCLUSION CRITERIA: randomised controlled trials reported in English which involved women experiencing: normal or 'low risk' pregnancy; intrapartum interventions; women who had a spontaneous onset of labour. DATA EXTRACTION: timing of consent and randomisation, proportion of eligible women recruited, 'losses' to the study. Included Studies fourteen published and one unpublished study that fitted the inclusion criteria were identified. Three studies were subsequently excluded because of a lack of information about the method and a further study was excluded due to its small sample size.
FINDINGS: Three strategies for recruitment and randomisation for intrapartum studies were reported in the literature: antenatal recruitment and randomisation; consent and randomisation conducted on admission in labour or at the time of the intervention; staged recruitment and randomisation, which may be two- or three-staged. Different study designs have done much to improve the appearance of intrapartum studies and reduce post-randomisation losses. However, the problem of bias in RCTs is not limited to attrition alone and these designs may simply be moving the problem to an earlier stage in the study resulting in selection bias and limiting generalisability.
CONCLUSIONS: The importance of accurate documentation of numbers at all stages in the research process is highlighted, in particular the number of eligible people not recruited, to allow the reader to assess the generalisability of the study.

Entities:  

Mesh:

Year:  2004        PMID: 15020025     DOI: 10.1016/S0266-6138(03)00050-0

Source DB:  PubMed          Journal:  Midwifery        ISSN: 0266-6138            Impact factor:   2.372


  7 in total

1.  The purple line as a measure of labour progress: a longitudinal study.

Authors:  Ashley Shepherd; Helen Cheyne; Susan Kennedy; Colette McIntosh; Maggie Styles; Catherine Niven
Journal:  BMC Pregnancy Childbirth       Date:  2010-09-16       Impact factor: 3.007

2.  Participating in a trial in a critical situation: a qualitative study in pregnancy.

Authors:  S Kenyon; M Dixon-Woods; C J Jackson; K Windridge; E Pitchforth
Journal:  Qual Saf Health Care       Date:  2006-04

3.  No reduction in instrumental vaginal births and no increased risk for adverse perineal outcome in nulliparous women giving birth on a birth seat: results of a Swedish randomized controlled trial.

Authors:  Li Thies-Lagergren; Linda J Kvist; Kyllike Christensson; Ingegerd Hildingsson
Journal:  BMC Pregnancy Childbirth       Date:  2011-03-24       Impact factor: 3.007

4.  Striving for scientific stringency: a re-analysis of a randomised controlled trial considering first-time mothers' obstetric outcomes in relation to birth position.

Authors:  Li Thies-Lagergren; Linda J Kvist; Kyllike Christensson; Ingegerd Hildingsson
Journal:  BMC Pregnancy Childbirth       Date:  2012-11-22       Impact factor: 3.007

Review 5.  A thematic analysis of factors influencing recruitment to maternal and perinatal trials.

Authors:  Rebecca L Tooher; Philippa F Middleton; Caroline A Crowther
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-07       Impact factor: 3.007

6.  Effects of algorithm for diagnosis of active labour: cluster randomised trial.

Authors:  Helen Cheyne; Vanora Hundley; Dawn Dowding; J Martin Bland; Paul McNamee; Ian Greer; Maggie Styles; Carol A Barnett; Graham Scotland; Catherine Niven
Journal:  BMJ       Date:  2008-12-08

Review 7.  The ethical issues regarding consent to clinical trials with pre-term or sick neonates: a systematic review (framework synthesis) of the empirical research.

Authors:  E Wilman; C Megone; S Oliver; L Duley; G Gyte; J M Wright
Journal:  Trials       Date:  2015-11-04       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.